Skip to content
May 14, 2024

Equity.Guru

Investment information for the new generation

Search

clinical trials shroom stocks

Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic…
Studying clinical studies For many psychedelics companies, clinical trials are the most expensive part of their business model and the reason they need to raise so much capital. Finding…